Darden: Insider Selling Is Routine, But The Valuation-Growth Math Has Changed

The insider selling at Darden Restaurants (NYSE: DRI) in late July and early August is not a covert bearish signal. It's a standard post-earnings diversification window. Chief People Officer Sarah King sold 4,373 shares on July 29 (approximately $920,200), reducing her direct common stock to just 742 shares while retaining over 7,000 derivative securities. John Wilkerson, president of Olive Garden, sold 8,864 shares on August 5 (for a total value of $1,846,637) after exercising vested options, still holding roughly 18,800 shares. Across four insider transactions in late July, total sales came to about $2,561,329.05.

None of these executives sold out. All retained meaningful equity exposure through options or derivatives. The timing — clustered in the weeks after the June 25 fiscal-year-close earnings release — fits a routine liquidity pattern, not a coordinated verdict on Darden's future.

The question for investors isn't what the insiders are doing with a fraction of their portfolios. It's whether Darden's current multiple — 20.2 times trailing earnings, 23.2 times forward, and 12.4 times EV/EBITDA — makes sense given what the latest operating data tells us about the next fiscal year.

The answer tilts the stock toward Hold. The business is strong, but the valuation no longer offers enough cushion for the deceleration signals now visible in Darden's largest brand.

What changed in the last earnings print

Darden's fiscal 2026 fourth quarter (ended May 31) had good and not-so-good elements, separated by brand.

Adjusted EPS came in at $3.66, beating analyst expectations of $3.63. Full-year adjusted EPS reached $10.64, up 11.4% year-over-year. Total revenue for the quarter rose 13.7% to $3.72 billion, though 7.6 percentage points of that came from an extra week of operations in the fiscal calendar, not organic growth.

The same-store sales split is where the story shifts. LongHorn Steakhouse posted 9.5% same-store growth, well above the 7.1% consensus. The Other Business segment (Yard House, Chuy's) hit 4.6% against a 3% forecast. That's good.

Olive Garden, Darden's largest brand by volume, delivered 2.4% same-store growth, missing the projected 3.2%. That follows a Q3 figure of 3.2% for Olive Garden, itself a weaker quarter derailed in part by winter storms that temporarily shut up to 40% of locations. Fine dining (The Capital Grille, Ruth's Chris) posted just 1.9%, missing the 3.1% forecast.

The deceleration in Darden's flagship casual brand matters because Olive Garden contributes the largest share of system-wide volume. A slowdown there doesn't disappear behind LongHorn's strength.

More importantly, the fiscal 2027 guidance undershot what investors expected. Darden projected total sales of $13.60 billion to $13.75 billion versus analyst consensus of $13.72 billion at the top end. EPS guidance of $11.10–$11.35 missed the expected $11.40. Same-store sales guidance of 2.5–3.5% implies the company expects deceleration from the 4.5% full-year FY26 result.

That's not bad guidance. It's just not the kind of guidance that justifies a 23x forward multiple in a sector where same-store sales are the primary driver of multiple expansion.

The valuation test

Darden trades at 20.2x trailing earnings and 23.2x forward. Its PEG ratio (forward P/E divided by estimated earnings growth) sits at 1.19. For context, YUM! Brands trades at 18.6x trailing earnings, and Restaurant Brands International sits at 20.2x. Darden is not cheap relative to peers.

The EV/EBITDA multiple of 12.4x is reasonable in isolation, but that multiple assumes Darden's EBITDA guidance of $2.26 billion to $2.29 billion holds and that margins don't compress as the company opens 75 to 80 new restaurant openings and spends $875 million on capex in fiscal 2027.

What supports the current multiple is real operating quality. Return on invested capital runs at 31.4%, one of the best in the restaurant sector. Free cash flow over the trailing twelve months reached $1.09 billion on $1.85 billion of operating cash flow. The dividend yield of 2.9% sits atop a 24-year streak of consecutive increases, with the latest quarterly hike of 8% to $1.62 per share. A new $1.5 billion share repurchase program adds buyback support.

But the valuation also assumes Olive Garden stabilizes and fine dining doesn't slip further. If same-store sales land at the low end of the 2.5–3.5% guidance range, the 23x forward multiple becomes the kind of pricing that leaves investors vulnerable to multiple compression if a subsequent quarter confirms sustained deceleration.

The catalyst clock

Darden's next earnings release should fall around mid-September 2026 for fiscal Q1 2027. That's the first real test of whether the company's 2.5–3.5% same-store guidance holds up or whether Olive Garden's deceleration from the 4.0% full-year FY26 pace deepens. Summer quarters are typically weaker for full-service dining, so a low-end print wouldn't be catastrophic. But a reading below 2% would raise concerns.

The 75–80 new restaurant openings Darden plans for fiscal 2027 also add incremental revenue, but they come with $875 million in capex and the integration costs that typically depress margins in the first year. Darden's balance sheet can handle it — $1.09 billion in free cash flow provides runway — but the earnings accretion from new stores won't be visible until they mature.

Risks and what would change the rating

The downgrade case opens if Olive Garden's same-store growth falls below 2% in the next quarter or two, especially if traffic continues to decline. Darden already cut its Bahama Breeze brand and is converting or closing those locations. Further brand-level weakness would signal broader demand pressure rather than a single-brand issue. Margin compression from promotional intensity — the kind of price-pointed promotions Darden trimmed in Q3 before the winter storms hit — would compound the problem.

Theupgrade case requires Olive Garden to reaccelerate toward its 3.5–4% range, fine dining to stabilize above 3%, and same-store growth to consistently hit the top end of the 2.5–3.5% guidance band. If that happens and the stock stays near current levels, the 23x forward multiple becomes defensible and the 2.9% yield adds ballast.

Investor takeaway

The insider selling at Darden is a distraction. These executives are diversifying a portion of their post-vesting positions during a normal liquidity window, and they all retain meaningful equity exposure. The real question is whether Darden's valuation has caught up with its slowing growth trajectory.

At 20x trailing earnings and 23x forward, with same-store guidance implying deceleration, the stock has moved from the kind of multiple that rewards strong execution to the kind that demands it. That's a Hold, not a Sell. The business generates real cash, the dividend is growing, and LongHorn remains a standout. But the margin for error at this valuation is narrower than it was six months ago. Wait for a dip or for the next earnings report to confirm whether Olive Garden stabilizes before adding.

Hold. The next catalyst is the September fiscal Q1 2027 earnings release. Same-store growth at or above the top of the guidance range upgrades the case. Consistently low-end prints downgrade it.